Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic dexamethasone vs dexamethasone on gelfoam after myringotomy for sudden sensorineural hearing loss
IRCT201211062106N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in acute sensorineural hearing loss (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Hearing improvement. Started Dec 2011; status: completed.
02
Drugs
dexamethasone
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on IRCT201211062106N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201211062106N5.